GENEART AG will become part of the US-Based Biotechnology Company Life Technologies Corp.
Life Technologies acquires 58 % of GENEART shares via it´s German subsidiary Applied Biosystems Deutschland GmbH
The founders of GENEART AG Prof. Dr. Ralf Wagner, Prof. Dr. Hans Wolf, Dr. Marcus Graf, and individual members of the management as well as the venture capital companies EquiNet EarlyStage Capital and S-REFIT AG, have signed contracts with Applied Biosystems Deutschland GmbH for selling their GENEART shares.
Applied Biosystems Deutschland GmbH thus holds about 58% of GENEART AG shares and is planning a voluntary public tender offer for the remaining GENEART AG shares. Applied Biosystems Deutschland GmbH is the German subsidiary of Life Technologies Corporation, a California/US biotechnology company with 2009 revenues of 3.3B U.S. dollar and about 9,000 employees. Furthermore, a cooperation agreement between GENEART AG and Life Technologies has been concluded.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Apitope and Merck Serono Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Euthymia_(medicine)
Pharminox signs option to in-license novel telomere signalling targeted agents from Cancer Research Technology

“Dictionaries” make fluorescence-based data for integrative structure models and their dynamics accessible - 3D structures of biomolecules
Temporomandibular_joint
Category:Ayurveda
Thermo Fisher Scientific Forms Consortium to Drive Immunotherapy Research Across Europe

Sustainable use of CO2 using a modified bacterium

New label-free detection technique digitally counts intact SARS-CoV-2 virus particles in saliva or exhaled breath
Cenix signs RNAi research agreement with SYGNIS

Inauguration of world’s largest fermentation plant for cultures
